ENTPD1 and chronic obstructive pulmonary disease: All the ATP-degrading enzymes studied (ENTPD1, ENTPD2 and ENTPD3) showed a similar expression pattern in both NOS and COPD patients, with decreases in ENTPD1 and ENTPD2 expression and no changes in ENTPD3 expression.